Navigation Links
Elusive pancreatic stem cells found in adult mice
Date:1/24/2008

Just as many scientists had given up the search, researchers have discovered that the pancreas does indeed harbor stem cells with the capacity to generate new insulin-producing beta cells. If the finding made in adult mice holds for humans, the newfound progenitor cells will represent an obvious target for therapeutic regeneration of beta cells in diabetes, the researchers report in the Jan. 25 issue of Cell, a publication of Cell Press.

One of the most interesting characteristics of these [adult] progenitor cells is that they are almost indistinguishable from embryonic progenitors, said Harry Heimberg of the JDRF Center at Vrije Universiteit Brussel in Belgium and the Beta Cell Biology Consortium. In terms of their structure and gene expression, there are no major differences. They look and behave just like embryonic beta cell progenitors."

Insulin is required for cells to take up blood sugar, the bodys primary energy source. In people with certain types of diabetes, blood sugar rises due to an inability of pancreatic beta cells to produce insulin in sufficient quantities.

Previous studies had failed to demonstrate the existence of bona fide beta cell progenitors in the pancreas after birth. The elusiveness of this cell type reached a summit when genetic lineage tracing provided evidence that pre-existing beta cells, rather than stem/progenitor cells, are the major source of new beta cells in adult mice, the researchers said. Most people gave up looking because they are so few and so hard to activate, Heimberg said.

In the new study, Heimbergs team tied off a duct that drains digestive enzymes from the pancreas. That injury led to a doubling of beta cells in the pancreas within two weeks, they showed. The animals pancreases also began producing more insulin, evidence that the new beta cells were fully functional, Heimberg said. He suspects the regenerative process is sparked by an inflammatory response in the enzyme-flooded pancreas.

They further found that the production of new beta cells depends on a gene called Neurogenin 3 (Ngn3), which is known to play a role in the pancreas during embryonic development.

The most important challenge now is to extrapolate our findings to patients with diabetes, Heimberg said. Although he cautioned that any potential diabetes treatment remains far into the future, our findings reveal the significance of investigating the feasibility of (1) isolating facultative beta cell progenitors and newly formed beta cells from human pancreas in order to expand and differentiate them in vitro and transplant them in diabetic patients and (2) composing a mix of factors able to activate beta cell progenitors to expand and differentiate in situ in patients with an absolute or relative deficiency in insulin, the researchers wrote.


'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Related biology news :

1. Understanding hypertension in African Americans proves elusive
2. Fossil record reveals elusive jellyfish more than 500 million years old
3. Baumann lab identifies elusive telomere RNA subunit in single cell model
4. Obesity and lack of exercise could enhance the risk of pancreatic cancer
5. Low levels of key protein may indicate pancreatic cancer risk
6. Birth records hold pancreatic cancer clue
7. Naturally-occurring apple compounds reduce risk of pancreatic cancer
8. ESF EURYI award winner aims to stop cancer cells reading their own DNA
9. Newly created cancer stem cells could aid breast cancer research
10. AIDS interferes with stem cells in the brain
11. Clemson scientists shed light on molecules in living cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
Breaking Biology News(10 mins):
(Date:7/27/2017)... N.C., July 27, 2017 United Therapeutics Corporation ... financial results for the second quarter ended June 30, ... second quarter total net revenues reached $445 million, ... Martine Rothblatt, Ph.D., United Therapeutics Chairman and Chief ... is well-positioned given the large and growing number ...
(Date:7/26/2017)... ... 26, 2017 , ... Franz Inc ., an early ... for Knowledge Graphs, today announced Gruff v7.0 , the industry’s leading Graph ... and graph experts the ability to visually build queries and explore connections as ...
(Date:7/26/2017)... ... July 25, 2017 , ... Proscia Inc. , a software solutions ... featured panelist at 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer Goliath,” ... and emerging technology (AI, VR, Big Data) sectors are taking aim at cancer diagnosis ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... complex problems we face every day. This unique capability combines high resolution ... chemists, and manufacturers to deliver unprecedented datasets for chemical analysis, quality control, and ...
Breaking Biology Technology: